<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Our Companies - Alix</title>
    <link rel="stylesheet" href="portfolio.css?v=16">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <!-- Instrument Serif -->
    <link href="https://fonts.googleapis.com/css2?family=Instrument+Serif:ital,wght@0,400;1,400&display=swap" rel="stylesheet">
    <!-- IBM Plex Sans -->
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans:ital,wght@0,400;0,500;0,600;0,700;1,400&display=swap" rel="stylesheet">
    <!-- IBM Plex Sans Condensed -->
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans+Condensed:ital,wght@0,400;0,500;0,600;0,700;1,400&display=swap" rel="stylesheet">
    <!-- IBM Plex Mono -->
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Mono:ital,wght@0,400;0,500;0,600;0,700;1,400&display=swap" rel="stylesheet">
</head>
<body>
    <!-- Header/Navigation Bar (separate from content) -->
    <header class="header-bar">
        <!-- Logo -->
        <a href="index.html" class="logo" data-node-id="42:84">Alix</a>
        
        <!-- Line separator -->
        <div class="line-container" aria-hidden="true"></div>

        <!-- Navigation -->
        <nav class="navigation">
            <a href="our-approach.html" class="nav-item nav-approach" data-node-id="42:85">Our Approach</a>
            <a href="portfolio.html" class="nav-item nav-portfolio active" data-node-id="42:87">Portfolio</a>
            <a href="team.html" class="nav-item nav-team" data-node-id="42:86">Team</a>
            <a href="#" class="nav-item nav-bios" id="bios-trigger" role="button">Bios ↗</a>
        </nav>
    </header>
    
    <!-- Bios popup -->
    <div id="bios-popup" class="bios-popup-overlay" aria-hidden="true">
        <div class="bios-popup">
            <p class="bios-popup-text">Our new BIOS+ site is launching soon with additional features! In the meantime, follow our thinking at <a href="https://bioscommunity.substack.com/" target="_blank" rel="noopener noreferrer">BIOS+ on Substack</a>.</p>
            <button type="button" class="bios-popup-close" aria-label="Close">×</button>
        </div>
    </div>
    
    <div class="portfolio" data-name="Portfolio" data-node-id="42:81">

        <!-- Title -->
        <div class="title" data-node-id="42:89">
            <p class="title-text">Our Companies</p>
        </div>

        <!-- Filter Tabs -->
        <div class="filters" data-node-id="42:104">
            <button class="filter active">All</button>
            <div class="filter-dropdown">
                <button class="filter filter-dropdown-btn">Stage</button>
                <div class="dropdown-menu">
                    <button class="dropdown-item" data-filter="stage" data-value="seed">Seed</button>
                    <button class="dropdown-item" data-filter="stage" data-value="series-a">Series A</button>
                    <button class="dropdown-item" data-filter="stage" data-value="series-b">Series B</button>
                    <button class="dropdown-item" data-filter="stage" data-value="growth">Growth</button>
                </div>
            </div>
            <div class="filter-dropdown">
                <button class="filter filter-dropdown-btn">Category</button>
                <div class="dropdown-menu">
                    <button class="dropdown-item" data-filter="category" data-value="computational-health">Computational Health</button>
                    <button class="dropdown-item" data-filter="category" data-value="precision-therapeutics-platforms">Precision Therapeutics Platforms</button>
                    <button class="dropdown-item" data-filter="category" data-value="techbio-platforms">TechBio Platforms</button>
                    <button class="dropdown-item" data-filter="category" data-value="other">Other</button>
                </div>
            </div>
        </div>

        <!-- Table Headers -->
        <div class="table" role="table">
            <div class="table-header" role="row">
                <span class="table-cell company" role="columnheader">Company</span>
                <span class="table-cell stage" role="columnheader">Data/Stage</span>
                <span class="table-cell description" role="columnheader">Description</span>
                <span class="table-cell category" role="columnheader">Category</span>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">64X</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Parallelized cell-line engineering for gene therapy manufacturing</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">64x is developing massively parallelized cell‑line engineering technologies to boost viral vector manufacturing productivity for cell and gene therapies.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Lexi Rovner, Pam Silver, Jeffrey Way</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">—</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://64xbio.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="computational-health">
                <span class="table-cell company" role="cell">BASIL SYSTEMS</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Life-science business intelligence and regulatory analytics</span>
                <span class="table-cell category" role="cell">Computational Health</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Basil Systems delivers actionable life‑science business intelligence with software that analyzes regulatory, clinical, and market data to guide device and diagnostics strategy.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Anthony Cirurgiao</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.basilsys.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">CHEMIFY</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Digital chemistry platform for automated molecular synthesis</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Chemify is creating a digital chemistry platform that combines automated synthesis hardware with software to design, make, and test molecules at scale.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Lee Cronin</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2023</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.chemify.io" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-b" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">CIRCULARIS</span>
                <span class="table-cell stage" role="cell">Series B</span>
                <span class="table-cell description" role="cell">RNA-based tools for optimizing gene expression</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Circularis has developed RNA‑based screening tools to optimize gene expression, enabling more effective and tunable gene therapies, and was acquired by Ginkgo Bioworks.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Paul Feldstein, James Lincoln</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.circularis.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="computational-health">
                <span class="table-cell company" role="cell">CLORA</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Digital talent platform for life-science R&D projects</span>
                <span class="table-cell category" role="cell">Computational Health</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Clora is a digital talent platform that connects life‑science companies with vetted experts and teams for high‑priority R&D and clinical projects.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Rahul Chaturvedi</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.clora.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">CYTOSOLIX</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">pH-activated chemotherapies for targeted cancer treatment</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Cytosolix is developing pH‑activated chemotherapies that selectively release payloads in acidic tumor microenvironments to enhance efficacy and limit systemic toxicity.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Jeremy Burton</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2023</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.cytosolix.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">ELEGEN</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Cell-free DNA writing platform for next-gen medicines</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Elegen is building a full‑stack, cell‑free DNA writing platform that delivers long, clonal‑quality DNA at unprecedented speed and scale for next‑generation medicines.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Matt Hill</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://elegenbio.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">ENDPOINT</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Precision immunology with diagnostics and AI-driven insights</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Endpoint Health is enabling precision immunology by combining diagnostics, therapeutics, and AI‑driven insights to guide targeted treatment for immune‑driven diseases.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Jason Mellad, Diego Rey, Leo Celi</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2022</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://endpointhealth.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">EXTHYMIC</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Next-generation cell therapy manufacturing solutions</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Exthymic is building next‑generation cell therapy manufacturing solutions that aim to streamline production and improve the quality and scalability of cell‑based treatments.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">—</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.exthymic.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">GALATEA</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Diverse genomic datasets for equitable precision medicine</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Galatea Bio is unlocking genomic insights for under‑represented populations by building diverse genomic datasets and analytics to power equitable precision medicine.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Carlos Bustamante</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2022</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.galateabio.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">GENYRO</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">AI-driven DNA design and construction platform</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Genyro is building an AI‑driven DNA design and construction platform that makes DNA a predictive engineering material, enabling scalable writing of complex genomes for the emerging bioeconomy.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Aviad Havazelet, Kaihang Wang, Frances Arnold</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">—</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.genyro.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="other">
                <span class="table-cell company" role="cell">iORGANBIO</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Enabling Organ Transplant Innovation</span>
                <span class="table-cell category" role="cell">Other</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Enabling Organ Transplant Innovation</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2025</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="#" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">MYTHIC</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Antibody-drug conjugates with tunable internalization for solid tumors</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Mythic Therapeutics is creating antibody–drug conjugates with tunable internalization to enhance therapeutic potency and improve outcomes for patients with solid tumors.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Clay Siegall</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.mythictx.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">MYTHIC</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Antibody-drug conjugates with tunable internalization for solid tumors</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Mythic Therapeutics is creating antibody–drug conjugates with tunable internalization to enhance therapeutic potency and improve outcomes for patients with solid tumors.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Clay Siegall</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.mythictx.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="computational-health">
                <span class="table-cell company" role="cell">PAIR TEAM</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Technology-enabled care coordination for safety-net clinics</span>
                <span class="table-cell category" role="cell">Computational Health</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Pair Team provides technology‑enabled care coordination as a service, partnering with safety‑net clinics and community organizations to extend longitudinal care into patients' homes.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Neil Batlivala, Cassie Choi</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2023</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.pairteam.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">STRAND</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">Programmable, logic-gated mRNA therapies</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Strand Therapeutics engineers programmable, logic‑gated mRNA therapies that activate only in targeted cells, enabling safer and more precise gene‑encoded treatments.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Jake Becraft, Chris Smolke</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2025</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.strandtx.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="techbio-platforms">
                <span class="table-cell company" role="cell">STRM</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Non-viral gene delivery via engineered red blood cell particles</span>
                <span class="table-cell category" role="cell">TechBio Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">STRM.Bio is developing programmable non‑viral gene delivery using engineered red blood cell‑derived particles to expand access to genetic medicines.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Jon Rowley</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2023</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://strm.bio/" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">TEIKO</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Next-gen immune profiling with single-cell analytics</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Teiko Bio provides next‑generation immune profiling using high‑dimensional single‑cell analytics to reveal how patients' immune systems respond to therapies.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Jon Chen, Shani Stern, Josh Wiedrick</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2021</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.teikobio.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="seed" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">XILIS</span>
                <span class="table-cell stage" role="cell">Seed</span>
                <span class="table-cell description" role="cell">Patient-derived micro-organoids for precision oncology</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Xilis is advancing precision oncology with patient-derived MicroOrganoSphere micro‑organoids that more accurately predict therapeutic response and accelerate drug development.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Xiling Shen, David Hsu, Hans Clevers</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2020</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://xilis.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
            <div class="table-row" role="row" data-stage="series-a" data-category="precision-therapeutics-platforms">
                <span class="table-cell company" role="cell">ZAFRENS</span>
                <span class="table-cell stage" role="cell">Series A</span>
                <span class="table-cell description" role="cell">High-throughput single-cell screening for drug discovery</span>
                <span class="table-cell category" role="cell">Precision Therapeutics Platforms</span>
                <div class="expanded-details">
                    <div class="details-content">
                        <div class="detail-item">
                            <span class="detail-label">Description</span>
                            <span class="detail-value">Zafrens is building an integrated platform for high‑throughput single‑cell screening, linking rich phenotypic data with molecular readouts to accelerate drug discovery.</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Founder(s)</span>
                            <span class="detail-value">Bilal Malik</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Partnered</span>
                            <span class="detail-value">2022</span>
                        </div>
                        <div class="detail-item">
                            <span class="detail-label">Links</span>
                            <div class="detail-links">
                                <a href="https://www.zafrens.com" target="_blank" class="detail-link">Website</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            <div class="divider"></div>
        </div>
    </div>
    
    <!-- Footer -->
    <footer class="site-footer">
        <div class="footer-content">
            <div class="footer-social">
                <a href="https://www.linkedin.com/company/alix-ventures" target="_blank" class="social-icon linkedin" aria-label="LinkedIn">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M20.447 20.452h-3.554v-5.569c0-1.328-.027-3.037-1.852-3.037-1.853 0-2.136 1.445-2.136 2.939v5.667H9.351V9h3.414v1.561h.046c.477-.9 1.637-1.85 3.37-1.85 3.601 0 4.267 2.37 4.267 5.455v6.286zM5.337 7.433c-1.144 0-2.063-.926-2.063-2.065 0-1.138.92-2.063 2.063-2.063 1.14 0 2.064.925 2.064 2.063 0 1.139-.925 2.065-2.064 2.065zm1.782 13.019H3.555V9h3.564v11.452zM22.225 0H1.771C.792 0 0 .774 0 1.729v20.542C0 23.227.792 24 1.771 24h20.451C23.2 24 24 23.227 24 22.271V1.729C24 .774 23.2 0 22.222 0h.003z"/>
                    </svg>
                </a>
                <a href="https://www.youtube.com/channel/UCWadRaYPrE1kE4t9LuCd28w" target="_blank" class="social-icon youtube" aria-label="YouTube">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M23.498 6.186a3.016 3.016 0 0 0-2.122-2.136C19.505 3.545 12 3.545 12 3.545s-7.505 0-9.377.505A3.017 3.017 0 0 0 .502 6.186C0 8.07 0 12 0 12s0 3.93.502 5.814a3.016 3.016 0 0 0 2.122 2.136c1.871.505 9.376.505 9.376.505s7.505 0 9.377-.505a3.015 3.015 0 0 0 2.122-2.136C24 15.93 24 12 24 12s0-3.93-.502-5.814zM9.545 15.568V8.432L15.818 12l-6.273 3.568z"/>
                    </svg>
                </a>
                <a href="https://twitter.com/bios_community" target="_blank" class="social-icon twitter" aria-label="Twitter">
                    <svg width="20" height="20" viewBox="0 0 24 24" fill="currentColor">
                        <path d="M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-5.214-6.817L4.99 21.75H1.68l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z"/>
                    </svg>
                </a>
            </div>
            <div class="footer-columns">
                <div class="footer-column">
                    <h3 class="footer-heading">COMPANY</h3>
                    <ul class="footer-links">
                        <li><a href="team.html">Team</a></li>
                        <li><a href="portfolio.html">Companies</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">INSIGHTS</h3>
                    <ul class="footer-links">
                        <li><a href="our-approach.html">Our Approach</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">RESOURCES</h3>
                    <ul class="footer-links">
                        <li><a href="team.html?filter=partners#partners">Partners</a></li>
                        <li><a href="portfolio.html">Portfolio</a></li>
                    </ul>
                </div>
                <div class="footer-column">
                    <h3 class="footer-heading">CONTACT</h3>
                    <ul class="footer-links">
                        <li><a href="mailto:partners@alix.vc">Contact Us</a></li>
                    </ul>
                </div>
            </div>
        </div>
        <div class="footer-bottom">
            <p class="footer-copyright">© Alix Ventures 2026</p>
        </div>
    </footer>

    <script src="portfolio.js"></script>
    <script>
        (function() {
            var trigger = document.getElementById('bios-trigger');
            var popup = document.getElementById('bios-popup');
            var closeBtn = popup && popup.querySelector('.bios-popup-close');
            if (trigger && popup) {
                trigger.addEventListener('click', function(e) { e.preventDefault(); popup.classList.add('visible'); popup.setAttribute('aria-hidden', 'false'); document.body.style.overflow = 'hidden'; });
                popup.addEventListener('click', function(e) { if (e.target === popup) { popup.classList.remove('visible'); popup.setAttribute('aria-hidden', 'true'); document.body.style.overflow = ''; } });
                if (closeBtn) closeBtn.addEventListener('click', function() { popup.classList.remove('visible'); popup.setAttribute('aria-hidden', 'true'); document.body.style.overflow = ''; });
            }
        })();
    </script>
</body>
</html>
